What does Brefeldin do?

Published by Charlie Davidson on

What does Brefeldin do?

Brefeldin A is a drug that causes a reversible disruption of the Golgi by releasing the vesicle coat proteins and blocking the assembly of vesicles destined to move to the next compartment.

What cellular process does brefeldin a inhibit?

Brefeldin A inhibits vesicle formation and transport between the endoplasmic reticulum and the Golgi apparatus which ultimately results in collapse of the Golgi apparatus into the endoplasmic reticulum via membrane fusion.

What is the difference between GolgiStop and GolgiPlug?

A. The major difference between these two inhibitors is where they work within a cell. BD GolgiStop (monensin) works by accumulation of protein at the endoplasmic reticulum (ER) stage, while BD GolgiPlug (brefeldin) works with accumulation of protein at the golgi complex.

How do you dilute brefeldin A?

Brefeldin A Solution is supplied as a 1000X in DMSO, which should be diluted to 1X in cell culture medium. Store the Brefeldin A Solution (1,000X) between 2°C and 8°C. Note: DMSO freezes at this temperature. Dilute the 1000X solution to 1X in the tissue culture medium.

Is brefeldin a reversible?

Brefeldin A (BFA) is a fungal macrocyclic lactone and a potent, reversible inhibitor of intracellular vesicle formation and protein trafficking between the endoplasmic reticulum (ER) and the Golgi apparatus [1].

What is Golgi stop?

Description. The ex vivo addition of BD GolgiStop™, a protein transport inhibitor containing monensin, to in vitro- or in vivo-stimulated lymphoid cells blocks their intracellular protein transport processes. This results in the accumulation of cytokines and/or proteins in the Golgi complex.

How does PMA ionomycin work?

PMA activates protein kinase C, while ionomycin is a calcium ionophore, and stimulation with these compounds bypasses the T cell membrane receptor complex and will lead to activation of several intracellular signaling pathways, resulting in T cell activation and production of a variety of cytokines.

What is BFA treatment?

Brefeldin A (BFA) treatment stops secretion and leads to the resorption of much of the Golgi apparatus into the endoplasmic reticulum. This effect is reversible upon washing out the drug, providing a situation for studying Golgi biogenesis.

How are Brefeldin A and monensin different?

The two most widely used reagents are monensin and brefeldin A (BFA). These reagents differ somewhat in their mode of action, which might explain their different effects. Monensin is an inhibitor of trans-Golgi function, while BFA inhibits protein transport between the endoplasmic reticulum (ER) and the Golgi.

How are BFA and monensin proteins used in medicine?

Both proteins prevent protein secretion from the Golgi complex, but in very different ways. BFA was originally isolated from Eupenicillium bredfelianum and used as an anti-viral lactone antibiotic. Briefly, BFA functions by indirectly inhibiting intracellular protein transport from the endoplasmic reticulum (ER)…

When to add monensin to an intracellular stain?

When setting up an intracellular stain, let your cells incubate/culture with the stimulus for at least an hour before throwing monensin or BFA (or both) into the mix.

Can a brefeldin block the expression of CD69?

Brefeldin A, but not monensin, completely blocks CD69 expression on mouse lymphocytes: efficacy of inhibitors of protein secretion in protocols for intracellular cytokine staining by flow cytometry J Immunol Methods. 1999 Apr 22;224(1-2):69-76.doi: 10.1016/s0022-1759(99)00010-1. Authors S Nylander 1 , I Kalies

Categories: Helpful tips